18,19-Didehydroyohimban-17-one (54725-64-3)
| Identification |
| Properties |
| Safety Data |
| |
 |
Other Product
- Tricyclo[12.3.1.12,6]nonadeca-1(18),2,4,6(19),10,14,16-heptaen-9-one,17-hydroxy-3,11-dimethoxy-, (10E)-(+)-
- Tricyclo[12.3.1.12,6]nonadeca-1(18),2,4,6(19),10,14,16-heptaen-9-one,17-hydroxy-3,5,11-trimethoxy-, (10E)- (9CI)
- Tricyclo[12.3.1.12,6]nonadeca-1(18),2,4,6(19),14,16-hexaen-9-one,3-(b-D-glucopyranosyloxy)-17-hydroxy-
- 18-Norsarpagan-19(20H)-al,17-hydroxy-21- methyl-
- methyl 18-hydroxy-2β,16α-cur-19-en-17-oate
- Androst-4-en-17-one,19-hydroxy-
- 3β,19-Dihydroxyandrost-5-en-17-one
- 18-Norandrosta-4,13(17)-dien-3-one,17-methyl- (9CI)
- (16beta,17alpha,18beta,20alpha)-11,17-dimethoxy-16-(methoxycarbonyl)-18-[(3,4,5-trimethoxybenzoyl)oxy]-3,4-didehydroyohimban-4-ium
- dynorphin A (1-13), Tyr(14)-Leu(15)-Phe(16)-Asn(17)-Gly(18)-Pro(19)-
- 19-Norkauran-18-oicacid, 2-hydroxy-17-oxo-, (2b,4a,16a)- (9CI)
- methyl (19beta)-17-hydroxy-19-methyl-20,21-didehydro-18-oxayohimban-16-carboxylate
- 16,17-Didehydroyohimban
- Ibogamine-18-carboxylicacid, 13-methoxy-14-[(3a)-17-methoxy-17-oxovobasan-3-yl]-19-(2-oxopropyl)-, methyl ester (9CI)
- Ibogamine-18-carboxylicacid, 13-methoxy-14-[(3a)-17-methoxy-17-oxovobasan-3-yl]-19-oxo-, methyl ester (9CI)
- (19S)-19-Cyano-14-[(20α)-19,20-dihydro-17-methoxy-17-oxovobasan-3α-yl]-13-methoxyibogamine-18-carboxylic acid methyl ester
- (17S)-17-(Trimethylsiloxy)-19-norpregn-4-en-3-one
- Androst-5-en-17-one,3-(acetyloxy)-19-hydroxy-, (3b)-
- 17beta,19-dihydroxyandrost-4-en-3-one 17-benzoate
- 19-Norpregn-4-en-3-one,17-hydroxy-, (17a)-
